Abstract:We previously demonstrated that in Ifnar1 -/- Ifngr1 -/- or Stat1 -/- suckling mice lacking intact type I and type II interferon (IFN) signaling, rhesus rotavirus (RRV) infection causes a lethal disease with clinical manifestations similar to biliary atresia, including acholic stools, oily fur, growth retardation, and excess mortality. Elevated levels of viral RNA are detected in the bile ducts and liver of diseased pups together with severe inflammatory responses in these tissues. However, the viral determinants and the molecular mechanisms driving this process remain incompletely understood. Using an optimized rotavirus (RV) reverse genetics system, we generated a panel of recombinant RVs that encode non-structural protein 1 (NSP1) derived from different RV strains. We found that compared to the parental simian SA11 strain that is less biliary pathogenic, SA11 containing an RRV-derived NSP1 resulted in severe biliary obstructive disease comparable to that associated with RRV infection, reflected by high levels of viral RNA and inflammation in the biliary tract, liver, and pancreas. In contrast, RRV containing an SA11-originated NSP1 showed only mild biliary obstruction comparable to what was observed during SA11 infection. Infection with a monoreassortant RRV virus carrying NSP1 from the bovine RV UK strain also showed substantially reduced viral replication in extra-intestinal organs and did not develop clinical biliary diseases. Mechanistically, RRV NSP1 seemed to promote active viral replication in hepatocytes and this expanded tropism led to enhanced infiltration of CD4 and CD8 T cells, causing immunopathology and damage in the hepatobiliary system. These results highlight an unexpectedly important role of RV NSP1 in viral replication and disease progression in extra-intestinal tissues. In our research, we investigated how specific proteins from the rotavirus, a virus known for causing gastrointestinal infections, influence the severity of liver diseases in a special mouse model. We found that a protein called NSP1, which varies between different strains of the virus, plays a key role in how severe the liver disease becomes. Mice that lacked certain immune system components developed a serious liver condition similar to biliary atresia—a disease that affects the bile ducts and liver. When these mice were infected with a strain of rotavirus carrying NSP1 from another strain, they showed much more severe liver damage compared to those infected with a different strain. Our findings highlight the significant role of NSP1 in promoting viral replication in the liver and bile ducts. This research may help us understand whether and why some rotavirus strains cause more severe liver disease than others and could guide future studies aiming to develop better treatments for such infections. By uncovering these details, we aim to improve our understanding of rotavirus and its impact on the liver, potentially leading to better strategies for managing and treating related diseases.

Rhesus rotavirus NSP1 mediates extra-intestinal infection and is a contributing factor for biliary obstruction

Rotavirus NSP1 contributes to intestinal viral replication, pathogenesis, and transmission

Specific binding sites on Rhesus rotavirus capsid protein dictate the method of endocytosis inducing the murine model of biliary atresia

Viraemia and Extraintestinal Involvement after Rotavirus Infection

Rotavirus-induced murine biliary atresia is mediated by nuclear factor-κB

The rhesus rotavirus gene encoding VP4 is a major determinant in the pathogenesis of biliary atresia in newborn mice

The Rotavirus RNA-Binding Protein NS35 (NSP2) Forms 10S Multimers and Interacts with the Viral RNA Polymerase

A Genetically Engineered Rotavirus NSP2 Phosphorylation Mutant Impaired in Viroplasm Formation and Replication Shows an Early Interaction between vNSP2 and Cellular Lipid Droplets

N-Glycosylation of Rotavirus NSP4 Protein Affects Viral Replication and Pathogenesis

Reverse Genetics Reveals a Role of Rotavirus VP3 Phosphodiesterase Activity in Inhibiting RNase L Signaling and Contributing to Intestinal Viral Replication In Vivo

Rotavirus VP3 Targets MAVS for Degradation to Inhibit Type III Interferon Expression in Intestinal Epithelial Cells.

Rotavirus nonstructural protein 1 antagonizes innate immune response by interacting with retinoic acid inducible gene I

Viroporin activity from rotavirus nonstructural protein 4 induces intercellular calcium waves that contribute to pathogenesis

Rotavirus-induced lncRNA SLC7A11-AS1 promotes ferroptosis by targeting cystine/glutamate antiporter xCT (SLC7A11) to facilitate virus infection

Animal Model of Rhesus Rotavirus Induced Biliary Atresia Induced

MAVS Protein Is Attenuated by Rotavirus Nonstructural Protein 1

Segmented Filamentous Bacteria Prevent and Cure Rotavirus Infection

Rotavirus capping enzyme VP3 inhibits interferon expression by inducing MAVS degradation during viral replication

Rotavirus circumvents the antiviral effects of protein ISGylation via proteasomal degradation of Ube1L

RVFV virulence factor NSs triggers the mitochondrial MCL-1-BAK axis to activate pathogenic NLRP3 pyroptosis

[Factors Triggering Extraintestinal Infection of Rotavirus].